Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy
Authors:
- 22 October 2021
- journal article
- other
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 42 (1) , 43-70
Abstract
Despite new approaches in the diagnosis and treatment of tuberculosis (TB), it continues to be a major health burden. Several immunotherapies that potentiate the immune response have come up as adj...Keywords
This publication has 186 references indexed in Scilit:
- Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7Proceedings of the National Academy of Sciences, 2012
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor CellsCancer Cell, 2012
- Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptorsCurrent Opinion in Immunology, 2012
- Mycobacterium tuberculosisprotein tyrosine phosphatase (PtpA) excludes host vacuolar-H+–ATPase to inhibit phagosome acidificationProceedings of the National Academy of Sciences, 2011
- Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against TuberculosisCell Host & Microbe, 2011
- The Syk/CARD9-coupled receptor Dectin-1 is not required for host resistance to Mycobacterium tuberculosis in miceMicrobes and Infection, 2011
- Pattern Recognition Receptors and InflammationCell, 2010
- Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agentsProceedings of the National Academy of Sciences, 2010
- Pathogen Recognition and Innate ImmunityCell, 2006
- Mycobacterium tuberculosisglycosylated phosphatidylinositol causes phagosome maturation arrestProceedings of the National Academy of Sciences of the United States of America, 2003